SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
---|---|---|---|---|---|---|---|---|---|
10-Oct-24 9:57 PM View: | Chaturvedi Pravin R Chief Scientific Officer | Jaguar Health, Inc. (JAGX) | 08-Oct-24 | Grant | 4,922 | -- | -- | 14063% 35 to 4.96K | |
10-Oct-24 9:53 PM View: | King Steven R. see remarks | Jaguar Health, Inc. (JAGX) | 08-Oct-24 | Grant | 4,922 | -- | -- | 16972% 29 to 4.95K | |
10-Oct-24 9:55 PM View: | Conte Lisa A See Remarks Director | Jaguar Health, Inc. (JAGX) | 08-Oct-24 | Grant | 16,503 | -- | -- | 13639% 0.12K to 16.62K | |
10-Oct-24 9:58 PM View: | Lizak Carol R. Chief Financial Officer | Jaguar Health, Inc. (JAGX) | 08-Oct-24 | Grant | 4,280 | -- | -- | 23778% 18 to 4.3K | |
21-May-24 5:02 PM View: | Lizak Carol R. Chief Financial Officer | Jaguar Health, Inc. (JAGX) | 17-May-24 | Option Exercise | 431 | -- | -- | 60% 0.72K to 1.15K | |
21-May-24 5:03 PM View: | Wolin Jonathan S. Chief of Staff, CCO & GC | Jaguar Health, Inc. (JAGX) | 17-May-24 | Option Exercise | 871 | -- | -- | 76% 1.14K to 2.01K | |
21-May-24 5:04 PM View: | Chaturvedi Pravin R Chief Scientific Officer | Jaguar Health, Inc. (JAGX) | 17-May-24 | Option Exercise | 871 | -- | -- | 69% 1.27K to 2.14K | |
21-May-24 5:01 PM View: | King Steven R. see remarks | Jaguar Health, Inc. (JAGX) | 17-May-24 | Option Exercise | 612 | -- | -- | 53% 1.14K to 1.76K | |
21-May-24 5:00 PM View: | Conte Lisa A CEO and President Director | Jaguar Health, Inc. (JAGX) | 17-May-24 | Option Exercise | 2,695 | -- | -- | 59% 4.6K to 7.29K | |
17-Apr-24 4:31 PM View: | Lizak Carol R. Chief Financial Officer | Jaguar Health, Inc. (JAGX) | 05-Apr-24 | Option Exercise | 60 | -- | -- | 9% 0.66K to 0.72K | |
17-Apr-24 4:32 PM View: | Wolin Jonathan S. Chief of Staff, CCO & GC | Jaguar Health, Inc. (JAGX) | 05-Apr-24 | Option Exercise | 89 | -- | -- | 8% 1.05K to 1.14K | |
17-Apr-24 4:33 PM View: | Chaturvedi Pravin R Chief Scientific Officer | Jaguar Health, Inc. (JAGX) | 05-Apr-24 | Option Exercise | 134 | -- | -- | 12% 1.14K to 1.27K | |
17-Apr-24 4:31 PM View: | King Steven R. see remarks | Jaguar Health, Inc. (JAGX) | 05-Apr-24 | Option Exercise | 178 | -- | -- | 18% 0.97K to 1.14K | |
17-Apr-24 4:30 PM View: | Conte Lisa A CEO and President Director | Jaguar Health, Inc. (JAGX) | 05-Apr-24 | Option Exercise | 600 | -- | -- | 15% 4.0K to 4.6K | |
14-Aug-23 4:53 PM View: | Siegel Jonathan B. Director | Jaguar Health, Inc. (JAGX) | 14-Aug-23 | Grant | 68,568 | -- | -- | 5023% 1.36K to 69.93K | |
14-Aug-23 4:46 PM View: | King Steven R. see remarks | Jaguar Health, Inc. (JAGX) | 14-Aug-23 | Grant | 159,168 | -- | -- | 16494% 0.96K to 160.13K | |
14-Aug-23 4:50 PM View: | Chaturvedi Pravin R Chief Scientific Officer | Jaguar Health, Inc. (JAGX) | 14-Aug-23 | Grant | 204,192 | -- | -- | 17975% 1.14K to 205.33K | |
14-Aug-23 4:45 PM View: | Conte Lisa A CEO and President Director | Jaguar Health, Inc. (JAGX) | 14-Aug-23 | Grant | 383,605 | -- | -- | 9590% 4.0K to 387.61K | |
14-Aug-23 4:51 PM View: | Micek John Director | Jaguar Health, Inc. (JAGX) | 14-Aug-23 | Grant | 68,568 | -- | -- | 565% 12.13K to 80.7K | |
14-Aug-23 4:49 PM View: | Wolin Jonathan S. Chief of Staff, CCO & GC | Jaguar Health, Inc. (JAGX) | 14-Aug-23 | Grant | 196,628 | -- | -- | 18691% 1.05K to 197.68K | |
14-Aug-23 4:55 PM View: | Jayasuriya Anula Director | Jaguar Health, Inc. (JAGX) | 14-Aug-23 | Grant | 68,568 | -- | -- | 3991% 1.72K to 70.29K | |
14-Aug-23 4:50 PM View: | Bochnowski James J Director | Jaguar Health, Inc. (JAGX) | 14-Aug-23 | Grant | 76,613 | -- | -- | 3385% 2.26K to 78.88K | |
14-Aug-23 4:48 PM View: | Lizak Carol R. Chief Financial Officer | Jaguar Health, Inc. (JAGX) | 14-Aug-23 | Grant | 142,088 | -- | -- | 1647% 8.63K to 150.71K | |
14-Aug-23 4:55 PM View: | Jayasuriya Anula Director | Jaguar Health, Inc. (JAGX) | 01-Jul-23 | Grant | 1,718 | -- | -- | 100% 0 to 1.72K | |
19-May-23 9:42 PM View: | Chaturvedi Pravin R Chief Scientific Officer | Jaguar Health, Inc. (JAGX) | 17-May-23 | Option Exercise | 870 | -- | -- | 327% 0.27K to 1.14K | |
19-May-23 5:01 PM View: | Conte Lisa A CEO and President Director | Jaguar Health, Inc. (JAGX) | 17-May-23 | Option Exercise | 2,694 | -- | -- | 206% 1.31K to 4.0K | |
19-May-23 5:04 PM View: | Bochnowski James J Director | Jaguar Health, Inc. (JAGX) | 17-May-23 | Option Exercise | 1,280 | -- | -- | 130% 0.98K to 2.26K | |
19-May-23 5:06 PM View: | Siegel Jonathan B. Director | Jaguar Health, Inc. (JAGX) | 17-May-23 | Option Exercise | 1,145 | -- | -- | 520% 0.22K to 1.36K | |
19-May-23 5:03 PM View: | Wolin Jonathan S. Chief of Staff, CCO & GC | Jaguar Health, Inc. (JAGX) | 17-May-23 | Option Exercise | 871 | -- | -- | 481% 0.18K to 1.05K | |
19-May-23 5:02 PM View: | Lizak Carol R. Chief Financial Officer | Jaguar Health, Inc. (JAGX) | 17-May-23 | Option Exercise | 431 | -- | -- | 5% 8.19K to 8.63K | |
19-May-23 5:01 PM View: | King Steven R. Chief of Sustainable Supply | Jaguar Health, Inc. (JAGX) | 17-May-23 | Option Exercise | 611 | -- | -- | 173% 0.35K to 0.96K | |
19-May-23 5:05 PM View: | Micek John Director | Jaguar Health, Inc. (JAGX) | 17-May-23 | Option Exercise | 1,145 | -- | -- | 711% 0.16K to 1.31K | |
20-Apr-23 5:18 PM View: | Wolin Jonathan S. Chief of Staff, CCO & GC | Jaguar Health, Inc. (JAGX) | 05-Apr-23 | Option Exercise | 88 | -- | -- | 95% 93 to 0.18K | |
20-Apr-23 5:19 PM View: | Lizak Carol R. Chief Financial Officer | Jaguar Health, Inc. (JAGX) | 05-Apr-23 | Option Exercise | 60 | -- | -- | 36% 0.17K to 0.23K | |
20-Apr-23 5:17 PM View: | King Steven R. Chief of Sustainable Supply | Jaguar Health, Inc. (JAGX) | 05-Apr-23 | Option Exercise | 177 | -- | -- | 100% 0.18K to 0.35K | |
20-Apr-23 5:19 PM View: | Chaturvedi Pravin R Chief Scientific Officer | Jaguar Health, Inc. (JAGX) | 05-Apr-23 | Option Exercise | 44 | -- | -- | 100% 44 to 88 | |
20-Apr-23 5:15 PM View: | Conte Lisa A CEO and President Director | Jaguar Health, Inc. (JAGX) | 05-Apr-23 | Option Exercise | 600 | -- | -- | 85% 0.71K to 1.31K | |
03-Jan-23 5:03 PM View: | Wolin Jonathan S. Chief of Staff, CCO & GC | Jaguar Health, Inc. (JAGX) | 31-Dec-22 | Private Purchase | 317 | $0.03 | $9.51 | 5% 6.67K to 6.98K | |
18-May-22 4:33 PM View: | Siegel Jonathan B. Director | Jaguar Health, Inc. (JAGX) | 18-May-22 | Option Exercise | 12,133 | -- | -- | 274% 4.42K to 16.56K | |
18-May-22 4:32 PM View: | Micek John Director | Jaguar Health, Inc. (JAGX) | 18-May-22 | Option Exercise | 12,133 | -- | -- | 100% 0 to 12.13K | |
18-May-22 4:33 PM View: | Divis Greg J Director | Jaguar Health, Inc. (JAGX) | 18-May-22 | Option Exercise | 12,133 | -- | -- | 100% 0 to 12.13K | |
18-May-22 4:36 PM View: | Bochnowski James J Director | Jaguar Health, Inc. (JAGX) | 18-May-22 | Option Exercise | 13,133 | -- | -- | 22% 60.63K to 73.77K | |
06-Apr-22 4:36 PM View: | Chaturvedi Pravin R Chief Scientific Officer | Jaguar Health, Inc. (JAGX) | 05-Apr-22 | Option Exercise | 3,333 | -- | -- | 100% 0 to 3.33K | |
06-Apr-22 4:32 PM View: | King Steven R. Chief of Sustainable Supply | Jaguar Health, Inc. (JAGX) | 05-Apr-22 | Option Exercise | 13,333 | -- | -- | 100% 0 to 13.33K | |
06-Apr-22 4:35 PM View: | Lizak Carol R. Chief Financial Officer | Jaguar Health, Inc. (JAGX) | 05-Apr-22 | Option Exercise | 4,513 | -- | -- | 57% 7.97K to 12.48K | |
06-Apr-22 4:34 PM View: | Wolin Jonathan S. Chief of Staff, CCO & GC | Jaguar Health, Inc. (JAGX) | 05-Apr-22 | Option Exercise | 6,666 | -- | -- | 100% 0 to 6.67K | |
06-Apr-22 4:31 PM View: | Conte Lisa A CEO and President Director | Jaguar Health, Inc. (JAGX) | 05-Apr-22 | Option Exercise | 45,000 | -- | -- | 562% 8.0K to 53.0K | |
30-Mar-22 9:26 PM View: | Conte Lisa A CEO and President Director | Jaguar Health, Inc. (JAGX) | 13-Sep-21 | Market Purchase | 7,968 | $2.51 | $19,999.70 | 22766% 35 to 8.0K | (67%) |
30-Mar-22 9:32 PM View: | Lizak Carol R. Chief Financial Officer | Jaguar Health, Inc. (JAGX) | 13-Sep-21 | Market Purchase Duplicate | 7,968 | $2.51 | $19,999.70 | 100% 0 to 7.97K | (67%) |
07-Jun-21 4:38 PM View: | Bochnowski James J Director | Jaguar Health, Inc. (JAGX) | 04-Jun-21 | Market Sale | 152 | $1.74 | $264.48 | (< 1%) 954.54K to 954.39K | (2%) |